Wegener's Granulomatosis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials
